Volume 8, Number 3—March 2002
Novel Cryptosporidium Genotypes in Sporadic Cryptosporidiosis Cases: First Report of Human Infections with a Cervine Genotype
In this study, we genotyped parasites from the fecal specimens of sporadic cryptosporidiosis cases in British Columbia from 1995 to 1999. Genotyping was conducted by polymerase chain amplification of the internal transcribed spacer region, a hypervariable region in the 18S rRNA gene and the Cryptosporidium oocyst wall protein gene. Subsequent analysis was by restriction fragment length polymorphism and DNA sequencing. We identified two new Cryptosporidium genotypes in humans. One of these genotypes has been found recently in deer in New York state. The other genotype has not been identified in humans or animals. These results have important implications for drinking water quality strategies, especially for communities that obtain drinking water supplies from surface sources located in forested regions with deer populations.
In recent studies of cryptosporidiosis cases in North America, South America, Europe, and Australia, various polymorphic gene loci were used to show that two major genotypes of Cryptosporidium parvum occur in humans (1–10). Genotype 1, or the human genotype of C. parvum, has been isolated almost exclusively from humans and associated mainly with anthroponotic (human-to-human) transmission cycles (1). Experiments to infect animals such as cattle and mice with the human genotype have been unsuccessful, and the only in vivo model that exists for this genotype is a gnotobiotic piglet model (11). So far, the only animals reported to be infected with genotype 1 C. parvum are a monkey in the United States (5) and a dugong (Dugong dugon) in Australia (12). In contrast, genotype 2 or the calf genotype of C. parvum has been isolated from both human and bovine hosts, as well as other livestock and wild animals such as sheep, goats, and deer. Genotype 2 has been associated with zoonotic (animal-to-human) transmission cycles.
Other genotypes of C. parvum are found in animals,. including the dog, mouse, bear, pig, deer, and marsupial genotypes of C. parvum, which have been differentiated by sequence polymorphisms in the small subunit ribosomal RNA (13–15), the acetyl CoA synthetase (15), and heat shock protein 70 (16), as well as the Cryptosporidium oocyst wall protein (COWP) (17) genes, and named after the animals from which they were derived. Of these variant C. parvum genotypes, three human infections with the dog genotype have been reported—in an HIV patient (4), two Peruvian children (6), and a child in England (18). Aside from C. parvum, nine other Cryptosporidium species are recognized: C. felis (cat), C. muris (rodent), C. andersoni (cattle), C. wrairi (guinea pig), C. baileyi (bird), C. meleagridis (bird), C. serpentis (reptile), C. surophilum (lizard), and C. nasorum (fish). Although previously thought to be host specific, these other Cryptosporidium species have been associated with a few reports of human infections. C. felis (4,18,19) and C. meleagridis (19) have been found in immunocompromised persons. In addition, C. felis (6,18), C. meleagridis (6), and possibly C. muris (20) infections have been reported in children.
In this study, we genotyped parasites from the fecal specimens of sporadic cryptosporidiosis cases in British Columbia (BC). Genotyping was conducted by polymerase chain reaction (PCR) amplification of the internal transcribed spacer region, a hypervariable region in the 18S rRNA gene (4) and the COWP gene, (21). Subsequent analysis was by restriction fragment length polymorphism (RFLP) and DNA sequencing. We identified two new Cryptosporidium genotypes in humans. One of these genotypes has been found recently in deer in New York State (14). The other genotype has not been identified in humans or animals.
Cryptosporidiosis Cases and Community Information
C. parvum oocysts were isolated from patients in the Greater Vancouver and Fraser Valley Regional Districts of British Columbia over a 5-year period from 1995 to 1999. Demographic data on this geographic area have been described (2). Fecal specimens were collected from patients diagnosed with clinical symptoms consistent with cryptosporidiosis. Cryptosporidium oocysts were identified in stool specimens by standard concentration methods, acid-fast staining, and microscopy by the diagnostic parasitology laboratories to which the specimens were submitted. Oocyst-containing specimens were preserved in potassium dichromate solution (2.5% w/v) within 7 days of reception and stored at 4°C. The study was conducted retrospectively on specimens that were coded without personal identifiers. Informed consent from subjects was obtained.
Genomic DNA Extraction
Resuspended stool specimens were strained through cheesecloth. Potassium dichromate was removed by washing the sedimented filtrate 3 times in distilled water . Lipids were then extracted by using ethyl acetate as described (2). Cryptosporidium oocysts were disrupted by repeated freezing in a dry ice-ethanol bath and thawing in a boiling water bath in a 20% w/v suspension of Chelex-100 (BioRad Laboratories, Hercules, CA) as described (2). The DNA extracts were stored at –20°C.
PCR Amplification of C. parvum Oocyst DNA
Genomic DNA extracts from oocysts were centrifuged at 11,000 rpm (9,000 x g) for 20 minutes at 4°C and the supernatants used as template DNA for PCR. The PCR reaction was carried out as described (2) by using the forward primer, cry7, and the reverse primer CP5.8R to amplify the entire internal transcribed spacer 1 (ITS1) region, resulting in a 600-bp product. The amplification procedure using the CPBDIAGF/CPBDIAGR primer pair described by Pieniazek et al. (4) was used to amplify the hypervariable region of the 18S rRNA gene, and the CRY-9/CRY-15 primer pair described by Patel et al. (21) was used for the COWP gene.
In addition, genomic DNA prepared from oocysts that had either been characterized in previous studies (1,2) or were isolated from well-defined sources were included as known genotype controls. Genotype 2 controls included one bovine isolate from a purified batch of Iowa strain oocysts that had been passaged in calves at the University of Arizona; two human isolates from 1996 Cranbrook and 1998 Chilliwack outbreak cases, where animals infected with cryptosporidiosis were found in the watershed area ( and Ong et al., unpub. data); and five other human isolates derived from sporadic cases in British Columbia that have been described in a previous study as C. parvum genotype 2 isolates (2). Genotype 1 controls included seven isolates from sporadic cases and one isolate from a 1996 Kelowna outbreak case (2), all identified previously as C. parvum genotype 1 isolates (2). Deionized water and a culture of a nonpathogenic strain of Escherichia coli were used as negative controls.
RFLP Analyses of PCR Products
PCR products were purified by using QIAquick spin columns (Qiagen, Mississauga, ON) according to the manufacturer’s instructions before digestion with the restriction endonucleases Mse I (New England BioLabs, Mississauga, ON) for the ITS1 locus and Rsa I (New England BioLabs) for the COWP gene. Two units of enzyme were added to a final volume of 20 μL containing 15 μL of PCR product and the appropriate dilution of the manufacturer’s recommended buffer, and then incubated overnight at 37°C. Restriction fragments were then separated on Metaphor FMC agarose gels (3% for Mse I digests of ITS1 products and 3.2% for Rsa I digests of COWP products) (Mandel Scientific, Guelph, ON) and stained with ethidium bromide; the patterns were visualized with a UV transilluminator. DNA band sizes were analyzed by using the ProRFLP program version 2.38 (DNA ProScan Inc., Nashville, TN).
DNA Sequencing and Analyses
PCR products from the variable 18S rRNA and COWP gene loci were cleaned by spin column purification using the QIAquick PCR Purification kits (Qiagen). Sequencing reactions were conducted in both directions, i.e., from the 5’ and 3’-ends using the ABI Prism BigDye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA), and analyzed on an ABI 310 automated DNA analyzer (Applied Biosystems).
Overlapping bidirectional sequences were assembled by using the SeqManII (DNASTAR Inc., Madison WI) sequence analysis software. Consensus sequences obtained were aligned by using the ClustalX program (22), which was also used for calculating the phylogenetic tree by the neighbor-joining method with 1,000 replicates for bootstrap values. Published 18S rRNA gene reference sequences included in the multiple sequence alignment are listed below with their corresponding accession numbers: AF093491 (23) and AF087575 (4) for C. parvum genotype 1 human isolates; AF112569 (13) for a C. parvum simian isolate; AF087576 (4) and AF093490 genotype 2 isolates from a human and a bovine source, respectively; AF087574 (4) and AF112576 (13) for C. parvum “dog” genotype isolates from a human and a canine source, respectively; AF115377 (13), AF247535 (24), and AF112571 (13) for C. parvum pig, bear, and mouse genotype isolates, respectively; AF297511 (14), AF297512 (14), and AF297515 (14) for C. parvum “deer” genotype isolates; AF297503 (14) for a C. parvum muskrat isolate; AF087577 (4) and AF112575 (13) for C. felis from a human and a feline source, respectively; AF115378 (13), AF093498 (23), AF093496 (23), AF112574 (13), AF093495 (23), and AF093499 (23) for C. wrairi, C. muris, C. andersoni, C. meleagridis, C. baileyi, and C. serpentis. The phylogenetic tree was displayed visually by using TreeView (25). The C. muris, C. andersoni, and C. serpentis sequences were used in the outgroup, and the tree was rooted with this outgroup.
The 18S rRNA and COWP gene sequences of the 11 patient isolates listed in the table have been submitted to GenBank and assigned accession numbers AY030084 to AY030093 and AF411631 to AF411633. The BLAST server (http://www.ncbi.nlm.nih.gov/BLAST/) was used for DNA databases searches.
Cryptosporidium oocysts were isolated from fecal specimens of 150 sporadic cryptosporidiosis cases. Two characteristic restriction profiles were obtained for Mse I digests of the 600-bp ITS1 products (Figure 1). The first type of restriction profile (Figure 1, lanes 4 and 15) showed five major bands at approximately 270, 160, 90, 75, and 55 bp. The bovine isolate, patient isolates from the 1996 Cranbrook and the 1998 Chilliwack outbreaks, and 29 (19%) isolates from sporadic cases had this restriction profile. Based on results from previous molecular characterization of a number of these isolates (1,2), this restriction profile was considered to be the C. parvum genotype 2 restriction pattern. The second restriction pattern (Figure 1, lanes 5, 6, 14, and 16) with six major bands around 185, 150, 100, 60, 40, and 30 bp was obtained from isolates of 108 (72%) sporadic cases and the one patient from the 1996 Kelowna outbreak. This restriction profile was considered to be the C. parvum genotype 1 profile, based on results from previous molecular analyses on the other seven genotype 1 isolates that were included as human genotype controls (2).
Restriction profiles with varying patterns (Figure 1, lanes 7, 9 to 13 and 17) were obtained from 13 (9%) other human isolates. Of these, nine (6%) isolates had identical restriction profiles (Figure 1, lanes 7 and 9 to 12) with five major bands at 150, 85, 70, 45, and 35 bp and were designated cervine genotype isolates. The other four isolates had unique restriction profiles and could be split into two groups of two isolates, based on the similarity of banding patterns. These were CS33 (Figure 1, lane 8) and MH222 (data not shown), which both had restriction fragments at 175 and 50 bp and additional variant bands at 65 and 70 bp, respectively. The remaining two isolates VF383 had bands at 315 and 105 bp (Figure 1, lane 13) and TK348 had bands at 325 and 85bp (Figure 1, lane 17), respectively.
To identify the Cryptosporidium species and genotype of isolates with variant restriction profiles, sequencing of a polymorphic locus on the 18S rRNA gene was carried out. Eleven isolates were selected based on their ITS1 restriction patterns. These included one isolate (TK386) with a characteristic human genotype 1 restriction profile, three isolates (TK324, TK303, DE340) with patterns similar to the human genotype 1 restriction profile but with one restriction fragment shifted slightly in molecular size (e.g., Figure 1, lane 14), three cervine genotype isolates (MH205, TK320, DE302; Figure 1, lanes 7, 10, and 11), and four isolates (CS33, MH222, VF383, TK348) with unique variant profiles (Table). Comparison of the 18S rRNA gene sequences of these isolates with 22 other published reference sequences, derived from a variety of human and animal Cryptosporidium isolates by using multiple sequence alignment and phylogenetic analysis (Figure 2), showed that the 11 isolates fell into four main groups. The first group consisted of four isolates (TK386, TK324, TK303, and DE340) that had restriction profiles identical or similar to the characteristic human genotype 1 pattern and all human genotype 1 reference isolates. All human isolates in the genotype 1 group had the characteristic polyT repeat sequence reported previously (10,26) between positions nt 686 and 698. The second group consisted of three human isolates (TK320, DE302, and MH205) and two cervine genotype isolates (Figure 2). The sequences of these three human isolates in the hypervariable 18S rRNA region were identical to that of a genotype 3 deer isolate described by Perz and Le Blancq (14). The third group consisted of two isolates (VF383 and TK348) and a pig genotype isolate (Figure 2). Sequences between the two human isolates were variant from the pig genotype sequence at only two different nucleotide positions between nt 686 and 698. The fourth group consisted of two human isolates (MH222 and CS33) and a C. meleagridis isolate (Figure 2).
Twenty-five sporadic isolates were also characterized by using a second locus on the COWP gene. Rsa I digests of the 550-bp PCR products (Figure 3) also showed the same dimorphism as the ITS1 locus with two predominant restriction patterns. Of these, 10 (40%) isolates had fragments at approximately 285, 125, 105, and 35 bp, which were characteristic for genotype 1 isolates (Figure 3, lanes 7 and 8). Another six (24%) isolates had the genotype 2 restriction profile with fragments at 410, 105, and 35 bp (Figure 3, Lanes 4 to 6). One isolate (CS33) had a variant restriction profile (Figure 3, Lane 10) with bands at approximately 370, 290, and 150 bp, which were similar in size to fragments reported for a C. meleagridis isolate (26). The 18S rRNA gene sequence of this isolate (CS33) was identical to that of C. meleagridis. The other isolate (MH205), had a restriction profile that was identical to those obtained from genotype 1 isolates (Figure 3, lane 9). This isolate had an identical ITS1 restriction profile with eight other sporadic human isolates and an 18S rRNA gene sequence that grouped with deer genotype 3 isolates from New York (Figure 2). The COWP gene sequences of MH205 and another cervine genotype isolate TK320 were determined to be identical and novel, sharing only 90% and 91% identity with the COWP gene sequences of the human (AF248741) and bovine (AF248743) alleles, respectively. BLAST analysis showed most alignment (92% identity) with a pig COWP gene sequence (AF266270) (17). However, the cervine allele had identical RsaI restriction sites to the human allele at nt 34, 228, 512, and 618, whereas the bovine allele lacked the site at nt 228. The RFLP patterns could not be determined for the remaining seven isolates as insufficient PCR product was obtained. Over half (51%) of the isolates in this study were derived from pediatric patients <10 years of age, which accounted for seven of the nine cervine genotype infections as well as the two C. meleagridis infections.
This study describes the discovery of the first zoonotic infections in humans with a novel cervine Cryptosporidium parvum genotype. Perz and LeBlancq (14) described this genotype recently after characterizing 111 Cryptosporidium isolates from wildlife in New York state. Those researchers did not detect human infections with this genotype in cryptosporidiosis cases in New York City. Other molecular epidemiologic studies in England (8,18) of 1,705 cases also did not identify cervine genotype infections, although rare zoonotic infections in humans with the dog genotype of C. parvum as well as other Cryptosporidium species such as C. felis and C. meleagridis were found (27). It is possible that cervine genotype infections in humans were not identified because the novel deer genotype had not been reported at the time of the study. As well, the PCR/RFLP profile of the COWP gene from the cervine genotype isolate was identical to that obtained from human genotype 1 isolates. Sequencing of the COWP gene from two cervine genotype isolates confirmed that the human and cervine alleles had identical RsaI restriction sites. Therefore, RFLP analysis using this endonuclease could not differentiate between isolates with these two genotypes.
Xiao et al. (28) have also found this novel cervine genotype in storm water samples collected from a stream in the watershed area of New York State that contributes to the New York City water supply. The transmission of cryptosporidiosis from wildlife to humans in British Columbia is not surprising as many communities are supplied with unfiltered drinking water drawn from surface sources where Cryptosporidium spp. oocysts have been detected (29). Many of these watersheds are situated in remote forested areas, where wildlife such as deer are present in abundance. Deer with cryptosporidiosis infections have been identified in these watersheds (Ong et al., unpub. data). Therefore, to have as many as 6% of sporadic cases infected with this novel deer genotype is not an unexpected finding.
The ITS1 and 18S rRNA genes are reportedly multicopy genes with four copies of the Type A and one copy of the Type B rDNA units per haploid genome (30). The sequence divergence found between Type A and Type B units in the ITS1 region was a concern to us initially, as we first characterized the isolates using this locus before this report. However, Morgan et al. (31), who conducted a similar PCR-RFLP analysis of the ITS1 region, found that the restriction profiles were specific for different C. parvum genotypes. This study also indicated that intraorganism variation caused by the difference between Type A and Type B rDNA units may not be such a problem. Using primers to amplify the Type B unit, Morgan et al. (31) found that the Type A unit was amplified preferentially for human genotype isolates. To confirm that the observed variation in the ITS1 RLFP patterns was not due to heterogeneous products amplified from different copies of rDNA, further characterization of a select number of sporadic isolates was performed with the 18S rRNA as well as the COWP genes. Results from these additional analyses showed that isolates with distinctly different ITS1 RFLP patterns had different COWP RFLP patterns as well as 18S and COWP gene sequences. Therefore, ITS1 RFLP was useful for generating characteristic fingerprints that could distinguish between different C. parvum genotypes and Cryptosporidium species.
Using this method of genotyping, we were able to detect two new genotypes of C. parvum that had not been reported previously. Nine isolates (including three, MH205, TK320, and DE302, which had been characterized at the 18S locus; and two, MH201 and TK320, which had been characterized at the COWP locus) had the cervine genotype. Two other isolates (VF383 and TK348) had novel genotypes that were most closely related to a pig genotype isolate from Switzerland (13). These results have important implications for drinking water quality strategies, especially for communities that obtain drinking water supplies from surface sources located in forested regions with deer populations.
Dr. Ong is an assistant professor at the University of British Columbia and a senior scientist at the British Columbia Centre for Disease Control. Her research interests are in pathogenic protozoa.
We thank Claudia Sutherland, Saima Kassam, Merrilee Hughes, and Tracy Kirkham for stool specimen processing;Tara Bonham and Linda Simpson for patient stool specimens; Reuben Chen for the 18S gene sequence of CS33 and COWP gene sequence of MH205; Ian Wilson for the COWP gene sequence of TK320; and Sean Byrne and Dr. Swee Han Goh for advice on DNA sequencing and polymerase chain reaction.
Funding for this project was provided by grants #153 (97-2) and #163 (98-2) from the British Columbia Research Foundation.
- Peng MM, Xiao L, Freeman A, Arrowood MJ, Escalante AA, Weltman AC, Genetic polymorphism among C. parvum isolates: Evidence of 2 distinct human transmission cycles. Emerg Infect Dis. 1997;3:567–73.
- Ong CSL, Eisler DL, Goh SH, Tomblin J, Awad-El-Kariem FM, Beard CB, Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada. Am J Trop Med Hyg. 1999;61:63–9.
- Widmer G, Tzipori S, Fichtenbaum CJ, Griffiths JK. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J Infect Dis. 1998;178:834–40.
- Pieniazek NJ, Bornay-Llinares FJ, Slemenda SB, da Silva AJ, Moura IN, Arrowood MJ, New Cryptosporidium genotypes in HIV-infected persons. Emerg Infect Dis. 1999;5:444–9.
- Spano F, Putignani L, Crisanti A, Sallicandro P, Morgan UM, Le Blancq SM, Multilocus genotypic analysis of Cryptosporidium parvum isolates from different hosts and geographical origins. J Clin Microbiol. 1998;36:3255–9.
- Xiao L, Bern C, Limor J, Sulaiman I, Roberts J, Checkley W, Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis. 2001;183:492–7.
- Awad-El-Kariem FM. Does Cryptosporidium parvum have a clonal population structure? Parasitol Today. 1999;15:502–4.
- McLauchlin J, Amar C, Pedraza-Diaz S, Nichols GL. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. J Clin Microbiol. 2000;38:3984–90.
- Caccio S, Homan W, Camilli R, Traldi G, Kortbeek T, Pozio E. A microsatellite marker reveals population heterogeneity within human and animal genotypes of Cryptosporidium parvum. Parasitology. 2000;120:237–44.
- Morgan UM, Constantine CC, Forbes DA, Thompson RC. Differentiation between human and animal isolates of Cryptosporidium parvum using rDNA sequencing and direct PCR analysis. J Parasitol. 1997;83:825–30.
- Widmer G, Akiyoshi D, Buckholt MA, Feng X, Rich SM, Deary KM, Animal propagation and genomic survey of a genotype 1 isolate of Cryptosporidium parvum. Mol Biochem Parasitol. 2000;108:187–97.
- Morgan UM, Xiao L, Hill BD, O'Donoghue P, Limor J, Lal A, Detection of the Cryptosporidium parvum "human" genotype in a dugong (Dugong dugon). J Parasitol. 2000;86:1352–4.
- Xiao L, Morgan UM, Limor J, Escalante A, Arrowood M, Shulaw W, Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol. 1999;65:3386–91.
- Perz JF, Le Blancq SM. Cryptosporidium parvum infection involving novel genotypes in wildlife from Lower New York State. Appl Environ Microbiol. 2001;67:1154–62.
- Morgan UM, Sargent KD, Deplazes P, Forbes DA, Spano F, Hertzberg H, Molecular characterization of Cryptosporidium from various hosts. Parasitology. 1998;117:31–7.
- Sulaiman IM, Morgan UM, Thompson RC, Lal AA, Xiao L. Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl Environ Microbiol. 2000;66:2385–91.
- Xiao L, Limor J, Morgan UM, Sulaiman IM, Thompson RC, Lal AA. Sequence differences in the diagnostic target region of the oocyst wall protein gene of Cryptosporidium parasites. Appl Environ Microbiol. 2000;66:5499–502.
- Pedraza-Diaz S, Amar C, Iversen AM, Stanley PJ, McLauchlin J. Unusual Cryptosporidium species recovered from human faeces: first description of Cryptosporidium felis and Cryptosporidium 'dog type' from patients in England. J Med Microbiol. 2001;50:293–6.
- Morgan U, Weber R, Xiao L, Sulaiman I, Thompson RC, Ndiritu W, Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol. 2000;38:1180–3.
- Katsumata T, Hosea D, Ranuh IG, Uga S, Yanagi T, Kohno S. Short report: possible Cryptosporidium muris infection in humans. Am J Trop Med Hyg. 2000;62:70–2.
- Patel S, Pedraza-Diaz S, McLauchlin J, Casemore DP. Molecular characterisation of Cryptosporidium parvum from two large suspected waterborne outbreaks. Outbreak Control Team South and West Devon 1995, Incident Management Team and Further Epidemiological and Microbiological Studies Subgroup North Thames 1997. Commun Dis Public Health. 1998;1:231–3.
- Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876–82.
- Xiao L, Escalante L, Yang C, Sulaiman I, Escalante AA, Montali RJ, Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus. Appl Environ Microbiol. 1999;65:1578–83.
- Xiao L, Limor JR, Sulaiman IM, Duncan RB, Lal AA. Molecular characterization of a Cryptosporidium isolate from a black bear. J Parasitol. 2000;86:1166–70.
- Page RDM. TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci. 1996;12:357–8.
- Xiao L, Limor JR, Li L, Morgan U, Thompson RC, Lal AA. Presence of heterogeneous copies of the small subunit rRNA gene in Cryptosporidium parvum human and marsupial genotypes and Cryptosporidium felis. J Eukaryot Microbiol. 1999;46:44S–5S.
- Pedraza-Díaz S, Amar C, McLauchlin J. The identification and characterisation of an unusual genotype of Cryptosporidium from human faeces as Cryptosporidium meleagridis. FEMS Microbiol Lett. 2000;189:189–94.
- Xiao L, Alderisio K, Limor J, Royer M, Lal AA. Identification of species and sources of Cryptosporidium oocysts in storm waters with a small-subunit rRNA-based diagnostic and genotyping tool. Appl Environ Microbiol. 2000;66:5492–8.
- Ong C, Moorehead W, Ross A, Isaac-Renton J. Studies of Giardia spp. and Cryptosporidium spp. in two adjacent watersheds. Appl Environ Microbiol. 1996;62:2798–805.
- Le Blancq SM, Khramtsov NV, Zamani F, Upton SJ, Wu TW. Ribosomal RNA gene organization in Cryptosporidium parvum. Mol Biochem Parasitol. 1997;90:463–78.
- Morgan UM, Deplazes P, Forbes DA, Spano F, Hertzberg H, Sargent KD, Sequence and PCR-RFLP analysis of the internal transcribed spacers of the rDNA repeat unit in isolates of Cryptosporidium from different hosts. Parasitology. 1999;118:49–58.
- Figure 1. Restriction profiles obtained after digestion of polymerase chain reaction products from the ITS1 locus with Mse I. lanes 1- 3-, 100-, 50-, and 10-bp ladder molecular weight markers; lanes...
- Figure 2. Phylogenetic relationship of isolates from sporadic cases with reference 18S rRNA gene sequences from various Cryptosporidium species and genotypes. Bootstrap values that are >95% are shown in larger font....
- Figure 3. Restriction profiles obtained after digestion of polymerase chain reaction products from the Cryptosporidium oocyst wall protein locus with Rsa I. Lanes 1- 3-, 100-, 50-, and 10-bp ladder molecular...
- Table. Analysis of Cryptosporidium isolates collected from 1995 to 1999 from sporadic cases in British Columbia, Canada
Suggested citation: Ong CSL, Eisler DL, Alikhani A, Fung VWK, Tomblin J, Bowie WR, et al. Novel Cryptosporidium Genotypes in Sporadic Cryptosporidiosis Cases: First Report of Human Infections with a Cervine Genotype. Emerg Infect Dis. [serial on the Internet]. 2002 Mar [date cited]. Available from http://wwwnc.cdc.gov/eid/article/8/3/01-0194
Please use the form below to submit correspondence to the authors or contact them at the following address:
Corinne S.L. Ong, Pathology & Laboratory Medicine, BC Centre for Disease Control Laboratory Services, 655 West 12th Avenue, Vancouver, British Columbia, Canada, V5Z 4R4; fax: 604-660-6073;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 15, 2010
- Page last updated: July 15, 2010
- Page last reviewed: July 15, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)